Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Point-of-Care Testing Market Is Growing

By HospiMedica staff writers
Posted on 22 Dec 2006
The need to diagnose and treat patients immediately is boosting the growth of the point-of-care testing (POCT) market in the United States and elsewhere.

According to a new study by Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, this market generated revenues of U.S.$1.3 billion in the United States alone in 2005, and is estimated to reach $2.4 billion by 2012.

"Point-of-care testing is becoming the standard of practice for an increasing number of diagnostics in areas such as glucose, blood gas and electrolytes, cholesterol, infectious diseases, and others,” noted Frost & Sullivan Research Analyst Kevin Leong. More...
"The speed and convenience of testing at the point-of-care is resulting in rapid medical intervention and improved patient outcomes.”

Immediate diagnosis and treatment increase patient satisfaction, avoid inefficiencies in administrative follow-ups, and minimize delays in treatments that could otherwise result in adverse complications and costly consequences. These benefits make it very attractive for medical professionals to adopt POCT and, in turn, fuel market growth.

However, the majority of diagnostic tests continue to be performed in centralized laboratories due to their long established use in medical practice. Physicians are primarily concerned with patient care, and rely on trained clinicians to perform quality diagnostics in laboratories. There remains a perception that point-of-care testing is inaccurate and inferior to laboratory analyzers.

Market participants need to emphasize the impact of rapid diagnostics for improved patient outcomes. Conducting compelling studies to support the accuracy and clinical utility of POCT will increase the comfort levels of healthcare practitioners with such methods. This also requires that POCT devices be user-friendly, ensuring quicker learning for immediate usage and adoption.



Related Links:
Frost & Sullivan

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.